Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

LOGIN HERE

Cancel

BSE Code : 524516 | NSE Symbol : | ISIN : INE711D01018 | Industry : Pharmaceuticals - Indian - Bulk Drugs |

Board Meeting

Announcement Date	Date Of Meeting	Purpose	Detail
13-Jan-2025	21-Jan-2025	Quarterly Results	BACIL PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/01/2025 inter alia to consider and approve 1) the Un-Audited Financial Results along with Limited Review Report of the Company for the Quarter ended 31st December 2024. 2) Other routine business with the permission of the Chair. Outcome of Board meeting (As Per BSE Announcement Dated on: 21/01/2025)
12-Nov-2024	12-Nov-2024	EGM	Submission of Corrigendum to the Notice of EOGM dated 15/10/2024 submitted on 23/10/2024 as per attachment
16-Oct-2024	23-Oct-2024	Quarterly Results	BACIL PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/10/2024 inter alia to consider and approve 1) To consider and approve the Un-Audited Financial Results along with Statements of Assets and Liabilities and Cash Flow Statement of the Company for the Quarter and half year ended 30th September 2024. 2) Other routine business with the permission of the Chair. outcome of Board Meeting held on 23rd October 2024 (As Per BSE Announcement Dated on: 23/10/2024)
10-Oct-2024	15-Oct-2024	Acquisitions	BACIL PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/10/2024 inter alia to consider and approve items mentioned in the notice of Board meeting. Outcome of Board Meeting held on 15th October,2024 Approved the acquisition of 5527000 Equity shares of M/s. CNX Corporation Limited (CCL) subject to approval of members of the Company at ensuing Extra Ordinary General Meeting. Revised Outcome of Board Meeting due to clerical mistake in list of allotee. (As Per BSE Announcement dated on 15.10.2024)
21-Sep-2024	27-Sep-2024	Raising funds through Debt Instr.	BACIL PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/09/2024 inter alia to consider and approve matters stated in intimation OUTCOME OF BOARD MEETING HELD ON 27TH SEPTEMBER, 2024. (As per BSE Announcement Dated on 27/09/2024)
02-Sep-2024	02-Sep-2024	AGM	Approval Of Notice Of Annual General Meeting And Board Of Directors Report, Fixation Of Book Closure For AGM And Remote Evoting Facility, Appointment Of Scrutinizer Along With Routine Business.
31-Aug-2024	31-Aug-2024	Change in Directors	outcome of Board Meeting held on 31.08.2024
28-Aug-2024	28-Aug-2024	Change in Directors	1. Considered & Approved Appointment of Ms. Avani Savjibhai Godhaniya (DIN: 10387729) as an Additional Director in the category of Non-Executive - Independent Director in the Company, not liable to retire by rotation, on the Board of Directors of the Company with effect from 28th August, 2024 for a first term of 5 (five) Years, i.e upto 27th August,2029 subject to members approval at its General Meeting. 2. Considered & Approved Appointment of Mr. Dinesh Chander Notiyal (DIN: 10289995) as an Additional Director in the category of Non-Executive - Independent Director in the Company , not liable to retire by rotation, on the Board of Directors of the Company with effect from 28th August,2024 for a first term of 5 (five) Years, i.e upto 27th August,2029 subject to members approval at its General Meeting.
07-Aug-2024	14-Aug-2024	Quarterly Results	BACIL PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2024 inter alia to consider and approve 1. the Un-Audited Financial Results along with Limited Review Report for the Quarter ended 30th June 2024. 2. Any other item with permission of the Chair. Outcome of Board Meeting held on 14th August 2024 (As Per Bse Announcement Dated on 14.08.2024)
14-May-2024	21-May-2024	Accounts	BACIL PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/05/2024 inter alia to consider and approve 1. the Audited Financial Results along with Auditors Report and Statement of Asset and Liabilities and Cash Flow Statement for the Quarter and Year ended 31st March 2024. 2. Any other item with permission of the Chair. Outcome of Board Meeting held on 21 May 2024 Financial Results along with Auditors Report & Statement of Assets & Liabilities & Cash Flow statement for the quarter and year ended 31st March 2024 Intimation for appointment of Secretarial Auditor of the company. Intimation for appointment of Internal Auditor of the Company (As Per BSE Announcement Dated on 21/05/2024)
03-Feb-2024	13-Feb-2024	Quarterly Results	BACIL PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2024 inter alia to consider and approve 1. the Un-Audited Financial Results along with Limited Review Report for the Quarter ended 31st December 2023. 2. Other routine business with the permission of the Chair. Approved and adopted the Un-audited Financial Results along with Limited Review Report for the Quarter and Nine Months ended 31st December, 2023. Approved Limited Review Report for the Quarter ended 31st December, 2023. Other routine business with the permission of the Chair. Unaudited Financial Result for the quarter and nice months ended 31st December 2023 (As Per BSE Announcement Dated on: 13/02/2024)
02-Nov-2023	10-Nov-2023	Quarterly Results	BACIL PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2023 inter alia to consider and approve 1) To consider and approve the Un-Audited Financial Results along with Statements of Assets and Liabilities and Cash Flow Statement of the Company for the Quarter and half year ended 30th September 2023. 2) Other routine business with the permission of the Chair. 1. Considered and approved the Un-audited Financial Results along with Statements of Assets and Liabilities and Cash Flow Statement of the Company for the Quarter and half year ended 30th September, 2023 along with Limited Review Report for the Quarter ended 30th September, 2023. 2. Other routine business with the permission of the Chair. Financial results for the Quarter and Half year ended 30th September 2023. Considered and approved unaudited stand alone financial result of the company for the quarter and half year ended on 30th September, 2023 along with limited review report as per regulation 33 of (listing obligation and disclosure requirement) regulation, 2015. (As Per BSE Announcement Dated on 10.11.2023) Submission of Financial Result for quarter & half year ended 30th September,2023 (As Per BSE Announcement dated on 20.12.2023)
14-Sep-2023	14-Sep-2023	Change in Other Executives	Appointment of Company Secretary and Compliance Officer.
19-Aug-2023	19-Aug-2023	AGM	BOARD MEETING HELD ON 19TH AUGUST, 2023 & FOLLOWING BUSINEES WERE CONSIDERED: 1.Considered and Approved the Notice of 36th Annual General Meeting of the Company . 2. Considered and approved Board of Directors Report along with Annexures for the year ended 31st March, 2023. 3. Considered and approved appointment of Mr. Ganpat Dhondu Salekar as 'Manager 'for a term of 5 (Five) years subject to members approval in the ensuing AGM. ( Annexure I) 4. Considered and Approved the Book Closure and Record Date for the purpose of 36th AGM . 5. Considered and Approved E-Voting facility for the purpose of 36th Annual General Meeting. 6. Considered and approved appointment of Mr. Suhas Ganpule, Practicing Company Secretary Membership No. 12122 and CP. No.5722 as scrutinizer for 36th Annual General meeting. (Annexure II) 7. Other routine business with the permission of the chair.
07-Aug-2023	14-Aug-2023	Quarterly Results	BACIL PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2023 inter alia to consider and approve 1. Unaudited Financial Results for the quarter ended 30th June2023 along with Limited Review Report 2. Other Business. 3. Any other item with the permission of Chair. OUTCOME OF BOARD MEETING HELD ON 14TH AUGUST, 2023 FOR THE QUARTER ENDED, 30TH JUNE ,2023 (As Per BSE Announcement Dated on 14.08.2023)

1 2 3

LOGIN HERE

Bacil Pharma Ltd

Board Meeting